|
Volumn 47, Issue 1, 2008, Pages 78-82
|
Solasodine glycoalkaloids: A novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ALKALOID;
PLACEBO;
SOLAMARGINE;
SOLASODINE;
SOLASONINE;
UNCLASSIFIED DRUG;
ZYCURE;
ADULT;
AGED;
APPLICATION SITE IRRITATION;
ARTICLE;
BASAL CELL CARCINOMA;
CANCER RECURRENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MIXTURE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG STRUCTURE;
FEMALE;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PARALLEL DESIGN;
RANDOMIZED CONTROLLED TRIAL;
SCAR FORMATION;
SKIN BIOPSY;
TOPICAL TREATMENT;
UNITED KINGDOM;
ADMINISTRATION, TOPICAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, BASAL CELL;
DOUBLE-BLIND METHOD;
FEMALE;
GLYCOSIDES;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
OCCLUSIVE DRESSINGS;
PATIENT DROPOUTS;
SKIN NEOPLASMS;
SOLANACEOUS ALKALOIDS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VEHICLES;
|
EID: 37449002213
PISSN: 00119059
EISSN: 13654632
Source Type: Journal
DOI: 10.1111/j.1365-4632.2007.03363.x Document Type: Article |
Times cited : (52)
|
References (12)
|